SELLAS shares tumble on interim trial results
Investing.com — SELLAS Life Sciences stock fell 14% following the outcome of the interim analysis for its pivotal Phase 3 REGAL trial of GPS in Acute Myeloid Leukemia (AML). The Independent (LON:IOG) Data Monitoring Committee (IDMC) recommended the
Micheál Martin returns as Irish prime minister amid Trump threat
By Padraic Halpin and Conor Humphries DUBLIN (Reuters) – Micheál Martin was elected Irish prime minister for the second time by a coalition of the country’s two large centre-right parties and independent lawmakers on Thursday, a day later than scheduled after
Hedge funds buy luxury, short drink and driving in Europe, says Goldman Sachs
By Nell Mackenzie LONDON (Reuters) – Hedge funds have turned optimistic about European companies that sell things people want but don’t necessarily need, especially luxury goods, according to a Goldman Sachs note on Wednesday seen by Reuters on Thursday. Consumer discretionary
US weekly jobless claims increase marginally
WASHINGTON (Reuters) – The number of Americans filing new applications for unemployment benefits rose marginally last week, suggesting that solid job growth likely continued in January. Initial claims for state unemployment benefits increased 6,000 to a seasonally adjusted 223,000 for
Freeport-McMoRan beats fourth-quarter profit estimates
(Reuters) -Miner Freeport-McMoRan (NYSE:FCX) beat fourth-quarter profit estimates on Thursday, helped by higher copper prices. Average copper prices rose in the fourth quarter, helped by signs of more stimulus in top consumer China, falling inventories and as U.S. job growth accelerated